From: A prospective CSFV-PCV2 bivalent vaccine effectively protects against classical swine fever virus and porcine circovirus type 2 dual challenge and prevents horizontal transmission
Groups and vaccines
Immunization
CSFV-PCV2 bivalent vaccine (n = 5)
Intraperitoneally immunized (0.5Â mL/dose) two doses at 6, 8Â weeks of age
Placebo (n = 5)